Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | HBM7008 |
Synonyms | |
Therapy Description |
HBM7008 is a bispecific antibody targeting VTCN1 (B7-H4) and TNFRSF9 (4-1BB), which potentially results in activation of T-lymphocytes and antitumor activity (Journal for ImmunoTherapy of Cancer 2022;10). |